Robeco Institutional Asset Management
MYGN icon

Robeco Institutional Asset Management’s Myriad Genetics MYGN Stock Holding History

Robeco Institutional Asset Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-228,220
Closed -$6.64M – 979
2018
Q4 		$6.64M Hold
228,220
– – 0.03% 487
2018
Q3 		$10.5M Hold
228,220
– – 0.04% 425
2018
Q2 		$8.53M Hold
228,220
– – 0.04% 436
2018
Q1 		$6.74M Buy
228,220
+54,122
+31% +$1.83M 0.03% 476
2017
Q4 		$5.98M Buy
+174,098
New +$5.87M 0.03% 464
2014
Q3 		– Sell
-78,188
Closed -$3.04M – 776
2014
Q2 		$3.04M Hold
78,188
– – 0.02% 376
2014
Q1 		$2.67M Hold
78,188
– – 0.02% 375
2013
Q4 		$1.64M Hold
78,188
– – 0.01% 387
2013
Q3 		$1.84M Hold
78,188
– – 0.02% 386
2013
Q2 		$2.1M Buy
+78,188
New +$2.27M 0.02% 367

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Robeco Institutional Asset Management's MYGN Position: Q1 2019 in Review

Robeco Institutional Asset Management sold out of Myriad Genetics (MYGN) in Q1 2019, closing a stake of 228,220 shares — an estimated $6.64M sold.

Robeco Institutional Asset Management first reported a position in MYGN in Q2 2013 and held it in 10 quarters. The position peaked at $10.5M in Q3 2018. 262 funds tracked by Wall St. Rank hold MYGN as of Q1 2019.

  • Robeco Institutional Asset Management reported no remaining Myriad Genetics position as of Q1 2019 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 228,220 Myriad Genetics shares in Q1 2019, an estimated $6.64M.
  • Robeco Institutional Asset Management first reported a position in Myriad Genetics in Q2 2013 and held it in 10 quarters.
  • Robeco Institutional Asset Management's Myriad Genetics position peaked at $10.5M in Q3 2018.
  • 262 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2019.

Based on Robeco Institutional Asset Management's 13F filing for Q1 2019, filed 2 May 2019.